Teladoc Health (TDOC) Receivables (2014 - 2026)

Teladoc Health has disclosed Receivables across 13 years of filings, most recently posting $230.9 million for Q2 2026.

• In Q2 2026, Receivables fell 1.33% year-over-year to $230.9 million; the TTM figure through Jun 2026 stood at $230.9 million (down 1.33% YoY), while the FY2025 annual figure was $201.7 million, down 9.96% from the prior year.
• Receivables came in at $230.9 million for Q2 2026 at Teladoc Health, up from $222.5 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $243.2 million in Q1 2025 to a low of $201.7 million in Q4 2025.
• Average Receivables over 5 years is $226.6 million, with a median of $227.4 million recorded in 2022.
• Year-over-year, Receivables climbed 27.01% in 2022 and fell 9.96% in 2025.
• Over 5 years, Receivables stood at $235.6 million in 2022, then fell by 2.37% to $230.1 million in 2023, then fell by 2.65% to $224.0 million in 2024, then slipped by 9.96% to $201.7 million in 2025, then gained by 14.49% to $230.9 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $230.9 million in Q2 2026, $222.5 million in Q1 2026, and $201.7 million in Q4 2025.